Virtu Financial’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-8,967
Closed -$538K – 2415
2021
Q1
$538K Buy
+8,967
New +$325K 0.04% 488

Virtu Financial's PAND Position: Q2 2021 in Review

Virtu Financial sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 8,967 shares — an estimated $538K sold.

Virtu Financial first reported a position in PAND in Q1 2021 and held it in 1 quarter. The position peaked at $538K in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

  • Virtu Financial reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Virtu Financial sold 8,967 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $538K.
  • Virtu Financial first reported a position in Pandion Therapeutics Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Virtu Financial's Pandion Therapeutics Inc. Common Stock position peaked at $538K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Virtu Financial's 13F filing for Q2 2021, filed 17 Sep 2021.